TOKYO -- COVID-19 vaccine manufacturers will have produced a total of more than 12 billion doses by the end of 2021, enough to cover the portion of the world's population needed for herd immunity, a report shows.
G-7 holds big surpluses of shots while developing nations lack access, report says

Vials of the Pfizer-BioNTech COVID-19 vaccine are prepared for packaging at Pfizer's facility in Puurs, Belgium. (Pfizer via AP)
TOKYO -- COVID-19 vaccine manufacturers will have produced a total of more than 12 billion doses by the end of 2021, enough to cover the portion of the world's population needed for herd immunity, a report shows.